{"nct_id":"NCT01037127","title":"Study to Determine the Effectiveness of GSK1120212 in BRAF Mutation-positive Melanoma Previously Treated With or Without a BRAF Inhibitor","status":"COMPLETED","status_verified_date":"2014-01","start_date":"2009-11","start_date_type":null,"primary_completion_date":"2011-07","primary_completion_date_type":"ACTUAL","completion_date":"2013-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}